cell::explorer HTS Pro by Revvity

The identification of disease-relevant targets is an essential first step in the drug discovery process, and requires thorough validation of each target to ensure downstream success. Phenotype-oriented target identification and validation techniques enable direct correlations between genetic alterations and disease phenotype, reducing the risk of failure in this early stage. The cell::explorer HTS pro is an integrated robotic platform to accelerate workflows such as: HTS workflows, including assay plate and compound preparation, Compound addition and phenotypic cell screening integrated platform, Immunoassay screening platform.